Trademark: 90468677
Word
ONEGATE
Status Date
Friday, April 12, 2024
Filing Date
Friday, January 15, 2021
Published for Opposition
Tuesday, August 17, 2021
42 Development of pharmaceutical preparations for the treatment of cancer; development of platform technology, namely, immunotherapy platforms for manufacturing cancer therapeutics; scientific research services, namely, antibody engineering for analytical and clinical purposes
Apr 16, 2021
New Application Office Supplied Data Entered
Jan 19, 2021
New Application Entered
Jun 20, 2021
Assigned To Examiner
Jul 11, 2021
Approved For Pub - Principal Register
Jul 28, 2021
Notification Of Notice Of Publication E-Mailed
Aug 17, 2021
Published For Opposition
Aug 17, 2021
Official Gazette Publication Confirmation E-Mailed
Oct 12, 2021
Noa E-Mailed - Sou Required From Applicant
Mar 29, 2022
Sou Teas Extension Received
Mar 29, 2022
Sou Extension 1 Filed
Mar 29, 2022
Sou Extension 1 Granted
Mar 31, 2022
Notice Of Approval Of Extension Request E-Mailed
Oct 12, 2022
Sou Teas Extension Received
Oct 12, 2022
Sou Extension 2 Filed
Oct 12, 2022
Sou Extension 2 Granted
Oct 14, 2022
Notice Of Approval Of Extension Request E-Mailed
Apr 11, 2023
Sou Extension 3 Filed
Apr 11, 2023
Sou Extension 3 Granted
Apr 13, 2023
Notice Of Approval Of Extension Request E-Mailed
Oct 12, 2023
Notice Of Approval Of Extension Request E-Mailed
Apr 12, 2024
Sou Extension 5 Filed
Apr 12, 2024
Sou Teas Extension Received
Apr 12, 2024
Sou Extension 5 Granted
Apr 13, 2024
Notice Of Approval Of Extension Request E-Mailed
Apr 11, 2023
Sou Teas Extension Received
Oct 10, 2023
Sou Teas Extension Received
Oct 10, 2023
Sou Extension 4 Filed
Oct 10, 2023
Sou Extension 4 Granted
Trademark Alertz updated from USPTO on 2030-01-24
